Destiny Pharma has appointed Nick Rodgers as an independent non-executive director. Nick has considerable Board experience in both public and private growth companies, particularly those in the life science sector, as well as a background as a successful corporate financier and investment banker. He is currently chairman of SEHTA, one of the largest health technology networking organisations in the UK. Prior to this, he was non-executive director and then chairman of fully listed Oxford Biomedica from 2004 until 2016. Previously, Nick headed up both the Life Science and Corporate Finance department at Evolution Beeson Gregory (now Investec) advising many life science listed companies from 1989 until 2003.